1. Medtech Insight
  2. >>Digital Technologies

How Israel's Digital Innovators Are Capturing The Minds Of Medtronic And Others

 
• By Catherine Longworth

The positive growth trend seen in Israel's digital health industry is galvanizing big players like Medtronic into action to start developing and recognizing synergistic technologies for future business. Medtech Insight met with members of MindUP, Israel's first digital health incubator and the result of a cross-industry partnership, at the MiXiii Biomed conference in Tel Aviv, to discover how the joint venture is driving the next generation of digital innovations.

Medical app
MindUP is Israel's first digital health incubator • Source: Shutterstock

With the explosion of Israeli digital health innovation in recent years, it was merely a matter of time before big players began to sit up and take notice. MindUP, a joint venture between Medtronic PLC, IBM, Pitango Venture Capital, Impact 1st Investments and Rambam Medical Center started activities in March 2016. As Israel's first incubator dedicated to digital health innovation, the program is focused on investment in the areas of big data, predictive analytics, telemedicine, cloud computing, wearable and implantable sensors, advanced point of care diagnostics and personalized medicine.

Through the two-year incubator program, entrepreneurs are promised "360-degree support" to help develop fully fledged companies that can reach market....

More from Digital Technologies

More from Medtech Insight

Execs On The Move: August 4–8, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

NAD Alerts Agendia Over Endorsing Physician’s Ties To Firm

 
• By Elizabeth Orr

The National Advertising Division (NAD) alerted Agendia to improve disclosure regarding a physician endorsing its MammaPrint test. The physician's ties to Agendia were inadequately revealed in LinkedIn posts.

FDA Ends Effort To Regulate LDTs By Rescinding Final Rule

 
• By Brian Bossetta

Just a year and four months after publishing a final rule that would have allowed it to regulate laboratory developed tests as medical devices, the US FDA has rescinded the controversial measure, finally putting an end to the saga.